IMS Health recently released its World Review 2015. The new general manager of North Latin America shares the company’s assessment on the…

IMS’s top consultant in Turkey discusses the common pattern that companies in Turkey have and must follow to adapt to today’s market, and the…

The president and founder of Knobloch Information Group, the leading supplier of market data to the pharmaceutical industry in Mexico, provides an…

IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s…

Al Z. Castro, General Manager of IMS Health Philippines, speaks about the ongoing challenges of bringing about awareness and acceptance of generics…

Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of austerity, and offers opinions on reference…

Mike Brogan, before taking up the mantle of President at IMS was VP of Business Integration at IMS for a year. Today, he talks about the difficulties…

Mr. Egan, what path led you to IMS Health? My original background is in science—I received a PhD in medical microbiology, and worked for some…

IMSS is a central pillar in the Mexican healthcare system, covering all Mexicans working for the declared formal private sector. How do you assess the…

Looking at your background, we see that you have been with IMS for over 12 years. What defines your loyalty to the company? What appeals most to you…

We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these…

Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why…